Medtronic plc
Medtronic
MDT · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2026
- Revenue
- $36.4B
- Assets
- $93B
- SEC filing
- DEF 14A
- Filed
- August 17, 2026
Executive Compensation
Compensation reported for Medtronic’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Geoff Martha
Chairman And Chief Executive Officer
$22.9M
Reported total
- Salary
- $1,399,039
- Stock awards
- $13,672,200
- Incentives
- $2,307,200
- Option awards
- $5,175,559
- Other
- $386,255
Thierry Piéton
EVP, Chief Financial Officer
$8.6M
Reported total
- Salary
- $849,648
- Stock awards
- $3,170,470
- Incentives
- $2,963,050
- Option awards
- $1,200,139
- Other
- $404,079
Brett Wall
Former Evp & President, Neuroscience Portfolio
$6.9M
Reported total
- Salary
- $799,519
- Stock awards
- $3,566,703
- Incentives
- $824,000
- Option awards
- $1,350,152
- Other
- $381,050
Mike Marinaro
EVP & President
$6.8M
Reported total
- Salary
- $819,616
- Stock awards
- $3,566,703
- Incentives
- $971,290
- Option awards
- $1,350,152
- Other
- $125,075
Michelle Quinn
EVP, General Counsel and Secretary
$6.7M
Reported total
- Salary
- $600,000
- Stock awards
- $3,481,600
- Incentives
- $1,717,423
- Option awards
- $750,082
- Other
- $170,065
Geoff Martha
Chairman And Chief Executive Officer
$22.9M
Reported total · FY2026 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed August 17, 2026.
- Salary
- $1.4M
- Stock Awards
- $13.7M
- Option Awards
- $5.2M
- Incentives
- $2.3M
- Other
- $386K
Historical Compensation
Geoff Martha total compensation, fiscal years 2024–2026.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2026 | $1,399,039 | $13,672,200 | $22,940,252 |
| 2025 | $1,350,000 | $12,625,000 | $21,240,058 |
| 2024 | $1,350,000 | $12,023,903 | $20,084,630 |
Named Executive Officers
Geoff Martha
Chairman And Chief Executive Officer
Medtronic · MDT
$22.9M
FY 2026 · DEF 14A
Thierry Piéton
EVP, Chief Financial Officer
Medtronic · MDT
$8.6M
FY 2026 · DEF 14A
Brett Wall
Former Evp & President, Neuroscience Portfolio
Medtronic · MDT
$6.9M
FY 2026 · DEF 14A
Mike Marinaro
EVP & President
Medtronic · MDT
$6.8M
FY 2026 · DEF 14A
Michelle Quinn
EVP, General Counsel and Secretary
Medtronic · MDT
$6.7M
FY 2026 · DEF 14A
Source information
- Company
- Medtronic plc
- Ticker
- MDT · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2026
- Filing date
- August 17, 2026
- SEC accession number
- 0001613103-26-000010
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →